The United Kingdom is witnessing a troubling rise in the use of anabolic steroids and experimental peptides, a trend that health professionals warn could lead to serious, even fatal, health consequences. With the proliferation of online marketplaces and social media platforms normalising these substances, experts argue urgent regulatory action is needed to safeguard public health.
A Lawless Landscape for Performance Enhancers
Professor Channa Jayasena, a consultant at Imperial College London, has raised alarms about the unregulated sale of experimental peptides and steroids. He notes that he encounters patients regularly who are injecting these potentially dangerous substances, highlighting a growing trend that appears to be spiralling out of control.
“The situation feels akin to a ‘wild west’ where individuals are freely administering powerful and often untested compounds,” Jayasena stated. He underscored the significant health risks associated with steroid use, including a threefold increase in mortality risk, and the potential dangers posed by peptides that may be manufactured in unregulated conditions, particularly in countries like China.
The Role of Social Media in Normalising Drug Use
This rising trend has been exacerbated by fitness influencers on platforms such as Telegram, where anabolic steroids and experimental substances are marketed as part of a wellness regimen. Susan Backhouse, a professor of sport psychology at Leeds Beckett University, emphasised that both men and women are increasingly dissatisfied with their physical appearance, contributing to the acceptance of enhancement practices across various demographics.
“Social media feeds are flooded with before-and-after images, which perpetuate the idea that these enhancements are not only acceptable but desirable,” Backhouse explained. The ease of access to these substances—often just a click away for consumers—raises significant concerns about self-experimentation and the long-term implications for health.
Regulatory Gaps Must Be Addressed
The lack of effective regulation is a critical issue, as Jayasena pointed out. He lamented that medical claims made by non-professionals go largely unchecked, creating a dangerous environment for consumers. The Medicines and Healthcare products Regulatory Agency (MHRA) struggles with enforcement, while the Advertising Standards Authority operates within a narrow scope.
Layla Moran, chair of the health select committee for the Liberal Democrats, echoed these concerns, citing the inability of tech companies to adequately protect users on their platforms. “The resources available to the MHRA and other regulatory bodies are insufficient to keep pace with the rapidly evolving landscape of online drug sales,” she said.
Conservative MP Luke Evans, a former general practitioner, has also been vocal about the need for increased awareness around image-enhancing drugs. He argues that many individuals using substances like steroids do not identify as drug users, complicating public perceptions and the approach to regulation.
Calls for Action and Awareness
Evans has advocated for a multi-pronged approach to tackle the issue, starting with open discussions about the risks involved. “The first step is to start talking about it; the second is to gather data; and finally, we need to determine accountability,” he said.
In response to the growing concern, a government spokesperson reiterated the seriousness with which the UK treats the illegal sale of medicines and harmful substances. They highlighted that the MHRA’s criminal enforcement unit actively investigates and disrupts illegal supply chains and takes necessary legal action.
Why it Matters
The normalisation of steroid and peptide use poses a significant public health threat, particularly among younger populations influenced by social media. As these substances become increasingly accessible, the potential for misuse and associated health risks climbs alarmingly. Without stringent regulations and an informed public, the UK could face a healthcare crisis, marked by rising incidences of severe health complications and fatalities linked to the unregulated use of performance-enhancing drugs.
